Verastem Oncology Announces 1-for-12 Reverse Stock Split
- ByInvesting.com-
Verastem Oncology, (Nasdaq: NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it will effect a 1-for-12...